Literature DB >> 16698439

Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity.

Luciana Lorena Molinero1, Carolina Inés Domaica, Mercedes Beatriz Fuertes, María Victoria Girart, Lucas Ezequiel Rossi, Norberto Walter Zwirner.   

Abstract

MICA is a stress-regulated molecule recognized by the NK cell-activating receptor NKG2D. Previously, we demonstrated that MICA is induced on activated T cells but regulation by mitogenic cytokines and its biological consequences remain unexplored. Here, we show that IL-2, IL-4, and IL-15 but not TNF-alpha or IFN-alpha induced MICA expression in T lymphocytes present in peripheral blood mononuclear cells (PBMCs), as assessed by Western blot. IL-2 effect involved Jak3/STAT5, p38 MAPK, p70(56) kinase, Lck/fyn kinases, and NF-kappaB. MICA expression was also observed in Th1 and Th2 cells. However, surface expression was not detected. T lymphocytes present in PBMCs and isolated CD4+ T lymphocytes stimulated with phorbol-12-myristate-13-acetate and ionomycin also induced MICA expression as assessed by Western blot, but only low levels were expressed at the cell surface. Activated but not resting CD4+ T lymphocytes were lysed by IL-15- or IL-2-stimulated NK cells, and susceptibility was increased when HLA class I molecules were blocked. Also, cytokine-stimulated NK cells produced more IFN-gamma after culture with activated CD4+ T lymphocytes. However, the participation of MICA in these responses, if any, was marginal. Confocal microscopy revealed that MICA is retained mostly inside activated CD4+ T cells. Our results suggest that low surface expression of MICA on activated CD4+ T lymphocytes might be a safeguard mechanism to protect them from NK cells in an inflammatory, virus-infected, or tumor microenvironment, where NK and activated CD4+ T cells are recruited.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698439     DOI: 10.1016/j.humimm.2006.02.010

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.

Authors:  Isabell Hamann; Nadine Unterwalder; Astrid E Cardona; Christian Meisel; Frauke Zipp; Richard M Ransohoff; Carmen Infante-Duarte
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

3.  Compartmental localization and clinical relevance of MICA antibodies after renal transplantation.

Authors:  Li Li; Amery Chen; Abanti Chaudhuri; Neeraja Kambham; Tara Sigdel; Rong Chen; Minnie M Sarwal
Journal:  Transplantation       Date:  2010-02-15       Impact factor: 4.939

4.  Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Authors:  Natasja Nielsen; Veronique Pascal; Andreas E R Fasth; Yvonne Sundström; Elisabeth D Galsgaard; David Ahern; Martin Andersen; Bo Baslund; Else M Bartels; Henning Bliddal; Marc Feldmann; Vivianne Malmström; Louise Berg; Pieter Spee; Kalle Söderström
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

5.  Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.

Authors:  Natasja Nielsen; Niels Ødum; Birgitte Ursø; Lewis L Lanier; Pieter Spee
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

6.  Acute Antibody-Mediated Rejection in Presence of MICA-DSA and Successful Renal Re-Transplant with Negative-MICA Virtual Crossmatch.

Authors:  Yingzi Ming; Juan Hu; Qizhi Luo; Xiang Ding; Weiguang Luo; Quan Zhuang; Yizhou Zou
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 7.  Natural killer cells in human autoimmune disorders.

Authors:  Leslie A Fogel; Wayne M Yokoyama; Anthony R French
Journal:  Arthritis Res Ther       Date:  2013-07-11       Impact factor: 5.156

8.  Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.

Authors:  Ajay Kumar Baranwal; Deepali Krishan Bhat; Sanjeev Goswami; Sanjay Kumar Agarwal; Gurvinder Kaur; Jasmeet Kaur; Narinder Mehra
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

9.  Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation.

Authors:  Cheol-Hun Son; Jin-Hee Keum; Kwangmo Yang; Jiho Nam; Mi-Ju Kim; Sun-Hee Kim; Chi-Dug Kang; Sae-Ock Oh; Chi-Dae Kim; You-Soo Park; Jaeho Bae
Journal:  Radiat Oncol       Date:  2014-02-10       Impact factor: 3.481

Review 10.  Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation.

Authors:  Sophia Lionaki; Konstantinos Panagiotellis; Aliki Iniotaki; John N Boletis
Journal:  Clin Dev Immunol       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.